How have ERG shares performed in 2024?

16611 (ERG.V)'s stock was trading at C$0.30 at the start of the year. Since then, ERG stock has increased by 0.0% and is now trading at C$0.30. View the best growth stocks for 2024 here .

How do I buy shares of 16611 (ERG.V)?

Shares of ERG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:ERG

16611 (ERG.V) (ERG) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free ERG Stock Alerts

C$0.30

0.00 (0.00%)

(As of 02/27/2018)

Compare

Today's Range: C$0.30
▼
C$0.30
50-Day Range: C$0.30
▼
C$0.30
52-Week Range: C$0.22
▼
C$0.30

Volume: 2,000 shs
Average Volume: 83,684 shs
Market Capitalization: C$21.39 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get 16611 (ERG.V) alerts:

Ad Manward Press

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

About 16611 (ERG.V) Stock (CVE:ERG)

Ergoresearch Ltd. operates in the healthcare sector. The Company manufactures and sells custom foot orthotics and general orthotics, and develops durable medical equipment for the orthopedic market. The Company is engaged in development of orthopedic solutions and products impacting pain management. The Company's products are non-invasive and non-toxic biomechanical devices, which feature patient benefits that are supported by clinical proof and scientific data. The Company designed and commercialized WebFit, a custom-fit orthotics manufacturing software program, and OdrA, an orthotic device. Its range of foot orthotics includes WebFit-Diabetes, WebFit-Gonosteoarthritis and WebFit. Its products also include podo-barometric sensor pads and scanners, and three dimensional (3d) scanner. The Company uses numerical control machine tools to manufacture its foot orthotics. It has approximately 10 laboratories.

ERG Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ERG Stock News Headlines

December 23, 2023 | reuters.com

ERG SpA

October 13, 2023 | msn.com

ERG enters cobalt supply deal with EVelution in US

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

August 18, 2023 | bizjournals.com

The state of ERGs

April 11, 2023 | npr.org

Morning Edition

April 11, 2023 | npr.org

All Things Considered

April 9, 2023 | npr.org

Weekend Edition Saturday

March 17, 2023 | forbes.com

ERG's: Are You Taking Advantage Of This Powerful Career Advancement Tool?

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

February 24, 2023 | theguardian.com

Sunak ‘relaxed’ about DUP and Tory backlash over Northern Ireland deal

See More Headlines

Receive ERG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 16611 (ERG.V) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Manufacturing
Industry: Electronic Computer Manufacturing
Sub-Industry: N/A
Current Symbol: CVE:ERG
CUSIP: N/A
CIK: N/A
Web: www.ergoresearch.com
Phone: +1-514-9313355
Fax: N/A
Employees: 147,000
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 72,509,000
Free Float: N/A
Market Cap: C$21.39 million
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Sylvain Boucher
President, Chief Executive Officer, Director
Dominique Boudreau
Vice President - Finance
Frederic Petit
Vice President - Operations
Danielle Boucher
Vice- President of Clinique du Pied Equilibre, Director
Gilles Laporte
Director
Catherine Chamouton
Independent Director
Michel Pierron
Independent Director
Francois Tellier
Independent Director

Key Competitors

View All Competitors

ERG Stock Analysis - Frequently Asked Questions

How have ERG shares performed in 2024?: 16611 (ERG.V)'s stock was trading at C$0.30 at the start of the year. Since then, ERG stock has increased by 0.0% and is now trading at C$0.30.
View the best growth stocks for 2024 here.
How do I buy shares of 16611 (ERG.V)?: Shares of ERG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:ERG) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

16611 (ERG.V) (ERG) Stock Price, News & Analysis

About 16611 (ERG.V) Stock (CVE:ERG)

ERG Stock Price History

ERG Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ERG Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info